Novartis Investigative Site

Beaumont, Texas 77702

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Ankylosing Spondylitis Clinical Trial
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Beaumont, TX
Click here to add this to my saved trials